ArticleBlood2024

An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma.

Katia Grillone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.